-
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03 Clinical Trial Optional)
(PA-18-601)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21 Clinical Trial Optional)
(PA-18-602)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01 Clinical Trial Optional)
(PA-18-603)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Methods Development in Natural Products Chemistry (R43/R44 Clinical Trial Not Allowed)
(PA-18-607)
National Center for Complementary and Integrative Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R41/R42 Clinical Trial Not Allowed)
(PA-18-609)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
*** Note new SBIR/STTR Standard Due Dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R43/R44 Clinical Trial Not Allowed)
(PA-18-610)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
*** Note new SBIR/STTR Standard Due Dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required)
(PA-18-613)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed)
(PA-18-614)
National Institute of Mental Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional)
(PA-18-615)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
-
Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R01 - Clinical Trial Optional)
(PA-18-619)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21 - Clinical Trial Optional)
(PA-18-620)
National Institute on Alcohol Abuse and Alcoholism
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Research to Support the Reduction and Elimination of Mental Health Disparities (Admin Supp Clinical Trial Optional)
(PA-18-621)
National Institute of Mental Health
Application Receipt Date(s): June 1, 2018; June 1,2019; June 1, 2020
-
Disease Mechanisms of Prenatal and Pediatric Hydrocephalus (R01 Clinical Trial Not Allowed)
(PA-18-622)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus (R21 Clinical Trial Not Allowed)
(PA-18-623)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIDA Small Research Grant Program (R03 Clinical Trial Required)
(PA-18-626)
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NIDA Academic Research Enhancement Award (R15, Clinical Trials Required)
(PA-18-627)
National Institute on Drug Abuse
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
(PAR-18-596)
National Institute on Aging
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): April 17, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
(PAR-18-597)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): July 2, 2018; November 2, 2018,
March 4, 2019, July 2, 2019; November 4, 2019
March 3, 2020, July 2, 2020, November 3, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
(PAR-18-598)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
Application Receipt Date(s): May 31, 2018), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed)
(PAR-18-599)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): May 31, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
(PAR-18-600)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
Application Receipt Date(s): May 31, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Vet-LIRN Network Capacity-Building Projects
(PAR-18-604)
Food and Drug Administration
Application Receipt Date(s): Jan 15, 2019, April 15, 2019, July 8, 2019
Jan 15, 2020, April 15, 2020, July 13, 2020
Jan 15, 2021, April 15, 2021, July 12, 2021
Jan 15, 2022, April 15, 2022, July 11, 2022
Jan 15, 2023, April 15, 2023, July 10, 2023
by 11:59 PM Eastern Time.
July 2, 2018
February 1, 2019, May 1, 2019, September 2, 2019
February 3, 2020, May 1, 2020, September 1, 2020
February 1, 2021, May 3, 2021, September 1, 2021
February 1, 2022, May 2, 2022, September 1, 2022
February 1, 2023, May 1, 2023, September 1, 2023
by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)
(PAR-18-605)
National Cancer Institute
Application Receipt Date(s): April 11, 2018; October 10, 2018; April 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)
(PAR-18-606)
National Cancer Institute
Application Receipt Date(s): April 11, 2018; October 10, 2018; April 11, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed)
(PAR-18-608)
National Center for Complementary and Integrative Health
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 Clinical Trial Optional)
(PAR-18-611)
Office of Disease Prevention
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): June 27, 2018; October 24, 2018; June 27, 2019; October 24, 2019; June 27, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 Clinical Trial Optional)
(PAR-18-612)
Office of Disease Prevention
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): June 27, 2018; October 24, 2018; June 27, 2019; October 24, 2019; June 27, 2020), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional)
(PAR-18-616)
National Cancer Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
NINDS Exploratory Clinical Trials for Small Business (R42) - Clinical Trial Required
(PAR-18-617)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization.
-
NINDS Exploratory Clinical Trials for Small Business (R44) - Clinical Trial Required
(PAR-18-618)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization.
-
Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional)
(PAS-18-624)
National Institute on Drug Abuse
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional)
(PAS-18-625)
National Institute on Drug Abuse
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Training Modules to Enhance the Rigor and Reproducibility of Biomedical Research (R25 Clinical Trial Not Allowed)
(RFA-GM-18-002)
National Institute of General Medical Sciences
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Application Receipt Date(s): June 29, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
National Centers for Translational Research in Reproduction and Infertility [NCTRI] (P50 - Clinical Trial Optional)
(RFA-HD-19-017)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): June 29, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Coordination Center for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (U24 Clinical Trial Not Allowed)
(RFA-HL-19-001)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): April 6, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed)
(RFA-HL-19-002)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): April 6, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.